13D Filing: Aisling Capital III LP and Transenterix Inc. (TRXC)

Page 10 of 12

Page 10 of 12 – SEC Filing

CUSIP No. 89366M102
SCHEDULE 13D/A
Page 10 of 12

Steve Elms
Dennis Purcell
Andrew Schiff
Common
Stock
Amount beneficially owned:
10,335,819
Percent of class:
(i) Sole voting power
0
(ii) Shared voting power
7.0
%
(iii) Sole dispositive power
0
(iv) Shared dispositive power
7.0
%
(b)
(i) Each of Aisling, Aisling Partners and Aisling Partners GP may be deemed to have sole power to direct the voting and disposition of the 10,335,819 shares of Common Stock that may be deemed to be beneficially owned by the Reporting Persons.
Aisling Capital III, LP
Aisling Capital Partners III, LP
Aisling Capital Partners III LLC
Common
Stock
Amount beneficially owned:
10,335,819
Percent of class:
(i) Sole voting power
7.0
%
(ii) Shared voting power
0
(iii) Sole dispositive power
7.0
%
(iv) Shared dispositive power
0
(ii) By virtue of the relationships between and among the Reporting Persons described in Item 2 of this Schedule 13D, each of the Messrs. Elms, Purcell and Schiff may be deemed to share the power to direct the voting and disposition of the 10,335,819 shares of Common Stock beneficially owned by the Reporting Persons.
Steve Elms
Dennis Purcell
Andrew Schiff
Common
Stock
Amount beneficially owned:
10,335,819
Percent of class:
(i) Sole voting power
0
(ii) Shared voting power
7.0
%
(iii) Sole dispositive power
0
(iv) Shared dispositive power
7.0
%
(c) Recent Transactions. On May 3, 2017, the Issuer sold  24,900,000 Units in a public offering at a public offering price of $1.00 per Unit.  Aisling purchased 2,000,000 Units in the offering.

Follow Asensus Surgical Inc. (NYSEMKT:ASXC)

Page 10 of 12